QinetiQ Group company profile
Company profile
QinetiQ Group has 7,500 employees and is headquartered in Farnborough, United Kingdom.
The company operates in the United States, Australia, Canada and Germany, providing science and technology solutions for the defence, security and infrastructure markets. Its activities range from test and evaluation, training and simulation, and mission rehearsal to cyber and intelligence capabilities, persistent surveillance and autonomous systems. Other offerings include advanced materials, quantum technology, directed energy systems and secure communication solutions. Its customers include ministries of defence, government agencies, departments of defense and commercial clients.
In the fiscal year ended March 2026, revenue was £1.9 billion, a decline of 0.5% from the previous fiscal year, and net income reached £107.5 million. The company employs 7,500 people. It was founded in 2001 and is headquartered in Farnborough, the United Kingdom.
Company facts
- Sector
- Technology
- Industry
- Aerospace & Defense
- Country
- United Kingdom
- Headquarters
- Cody Technology Park, GU14 0LX, Farnborough
- Employees
- 7,500
- Chief executive
- Stephen Wadey
- Founded
- 2001
- Fiscal year
- April - March
- Listing
- QQ. · LSE
- Currency
- GBp
- ISIN
- GB00B0WMWD03
- Website
- qinetiq.com
QinetiQ Group and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| QinetiQ GroupQQ. | United Kingdom | $3.24B | 7,500 | 12.5% | — |
| LisiFII | France | $3.3B | 9,455 | 9.8% | 35.1 |
| RENK GroupR3NK | Germany | $3.36B | 4,478 | 10.7% | 44.9 |
| ExosensEXENS | France | $2.78B | 2,000 | 17.4% | 119.0 |
| OHBOHB | Germany | $3.93B | 4,141 | 5.0% | 77.1 |
| Exail TechnologiesEXA | France | $2.35B | 2,332 | 7.4% | 25.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
